Latest results FY2026 · Prices updated Oct 30, 2026
HQ: Osaka, OsakaFounded 19544,714 employeesWebsite
A medical-device manufacturer producing dialysis-related products, injection and infusion supplies, and pharmaceuticals. It offers a broad range of products for healthcare providers and operates worldwide.
Business segments (share of revenue)
Latest results
FY2026
vs. same period a year earlier
Company forecastFY2027
| Segment | Share | Revenue | Operating profit | Margin |
|---|---|---|---|---|
| Medical Products | 79% | ¥523.6B | ¥52.3B | 10.0% |
| Pharmaceutical Products | 12% | ¥81.1B | ¥12.1B | 14.9% |
| Pharmaceutical Packaging | 8% | ¥54.7B | ¥-1.6B | -2.9% |
| Other Businesses | 0% | ¥1.1B | ¥940M | 83.3% |
Close (Oct 30, 2026)
¥1,363-9.0% (1Y)
Nipro -9.0% over 1Y, 17.7pt below the industry average (9 companies, +8.7%).
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Updated Oct 30, 2026.
| Period | Revenue | Op. profit | Net income | Total assets | Revenue YoY |
|---|---|---|---|---|---|
| 2026FY | ¥660.5B | ¥37.6B | ¥13.5B | ¥1.2T | — |
Sources: annual securities reports, earnings releases and other public disclosures (Jan 2026)
Data may contain input errors. For reference only; we accept no responsibility for its accuracy.
